Skip to main content

Artis Ventures — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

62
Companies
$2.7B
Total invested
$49.1M
Avg. check
41
Industries
Health Care 12Biotechnology 12Life Science 9Medical 6Artificial Intelligence (AI) 5Therapeutics 4+35 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 62
CURE: One app, all things health
September 2022

CURE is a healthcare on-demand company with the vision to be the easiest access to healthcare services without leaving your home.

Health Care · Berlin$15.0M Series A
Arkenstone Defense
July 2026

Arkenstone Defense is a compliance and operations software platform for defense contractors.

GovTech · Menlo Park$35.0M Seed
Replay
July 2022

Replay is a genome writing company reprogramming biology by writing and delivering big DNA.

Biotechnology · San Diego$55.0M Series A
Conceivable Life Sciences
July 2026

Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.

Artificial Intelligence (AI) · New York$18.0M Corporate Round
Valarian Technologies
July 2026

Valarian develops infrastructure and software for managing sensitive data, communications, and AI workloads in secure environments.

Artificial Intelligence (AI) · London$50.0M Series A
Siren Biotechnology
June 2026

Siren Biotechnology focuses on combining AAV gene therapy with cytokine immunotherapy to develop innovative treatments for cancer.

Biotechnology · San Francisco$8.0M Grant
Range Biotechnologies
June 2023

Range Biotechnologies is creating tools to enable personalized health through translational proteomics.

Biotechnology · San Carlos$5.2M Seed
MycoMedica Life Sciences, PBC
June 2022

MycoMedica Life Sciences, PBC develops fungi-based therapeutic drugs for psychiatric and neurological disorders.

Biotechnology · Shelton$60.0M Series A
Onto Health
April 2026

Onto Health offers tech-enabled fertility care, including IVF, egg freezing, IUI, and digital tools for personalized reproductive support.

Fertility · Parker$20.0M Series A
Science
March 2026

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

Biotechnology · Alameda$230.0M Series C
Tessera Therapeutics
March 2026

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Biopharma · CambridgeGrant
Unnatural Products
March 2026

Unnatural Products is a biotech company that focuses on unlocking macrocyclic peptides to create drug therapies.

Artificial Intelligence (AI) · Santa Cruz$45.0M Series B
Glyphic Biotechnologies
September 2025

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.

Biotechnology · New York$38.0M Series A
Delix Therapeutics
September 2025

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Biotechnology · Boston$25.0M Series B
Rad AI
May 2025

Rad AI develops software that uses AI to automate radiology report writing, aiming to enhance accuracy and reduce radiologist burnout.

Artificial Intelligence (AI) · San Francisco$8.0M Series C
Network Bio
February 2025

Network Bio's biomedical data for AI-enabled precision medicine

Bioinformatics · New York$17.0M Seed
Delfina
January 2025

Delfina provides a personalized prenatal care system that uses the power of data to keep moms and babies safe during pregnancy.

Health Care · San Francisco$17.0M Series A
Ozlo Sleep
October 2024

Ozlo Sleep is a science-driven sleep and audio technology company that simplifies sleep rituals without the use of medication.

Consumer Electronics · Northborough$12.0M Venture - Series Unknown
Outpace Bio
August 2024

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Biotechnology · Seattle$144.0M Series B
Eko Health
June 2024

Eko Health is a digital health company providing digital stethoscopes and an AI detection platform for diagnosing heart and lung diseases.

Artificial Intelligence (AI) · Emeryville$41.0M Series D
Enklu
January 2024

The spatial marketplace powering the only location-based AR network connecting players and developers in 5 countries and 22 markets.

Augmented Reality · Chicago$1.3M Seed
Athena Club
January 2024

Athena Club is an omnichannel subscription-based company that provides personal care products for women.

Consumer · New York$33.5M Venture - Series Unknown
Power Life Science
December 2023

Power Life Science is a patient-friendly platform that provides access to clinical trials by condition, location, and drug type.

Clinical Trials · San Francisco$11.9M Series A
Bettani
October 2025

Bettani creates plant-based ingredients and products using data-driven technology and culinary expertise.

Biotechnology · Berkeley$6.5M Series A

Where Artis Ventures invests

Health Care12
Biotechnology12
Life Science9
Medical6
Artificial Intelligence (AI)5
Therapeutics4

About Artis Ventures's portfolio

How many companies has Artis Ventures invested in?

Artis Ventures has invested in 62 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Artis Ventures invest in?

Artis Ventures's top investment sectors include Health Care, Biotechnology, Life Science, Medical, Artificial Intelligence (AI). The firm invests across 41 different industry categories.

What is Artis Ventures's largest investment?

Among tracked funding rounds, Science received $230.0M in a Series C round. Artis Ventures's total known invested capital is $2.7B.

What is the average investment size for Artis Ventures?

Artis Ventures's average investment size is $49.1M across its portfolio of 62 companies.

What are Artis Ventures's most recent investments?

Recent Artis Ventures portfolio additions include CURE: One app, all things health, Arkenstone Defense, Replay, Conceivable Life Sciences, Valarian Technologies. These companies were founded in 2020 or later.

Reach the founders behind these 62 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →